SCHEMBL20629314

SCHEMBL20629314

O=CC1=C(c2ccccc2)c2cc(O)ccc2OC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
ESR1 P03372 7/20 0.41
ESR2 Q92731 7/20 0.41
MIF P14174 2/20 0.41
AR P10275 1/20 0.38
KMT2A Q03164 2/20 0.37
MAOB P27338 2/20 0.37
MEN1 O00255 1/20 0.37
ACHE P22303 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALOX5 P09917 1/20 0.37
CYP26A1 O43174 1/20 0.36
APP P05067 2/20 0.36
PELI1 Q96FA3 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20628752 0.86 MAPT (0.41) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL18031760 0.86 ESR1 (0.44) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL7033347 0.82 MAOB (0.43) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL21294262 0.74 THRB (0.46) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL17085449 0.70 ALDH1A1 (0.49) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL21294303 0.69 MAPT (0.40) MAPTRAB9AESR1ESR2KMT2A
SCHEMBL30574498 0.69 MAPT (0.40) MAPTRAB9AESR1ESR2KMT2A
SCHEMBL2324085 0.68 MIF (0.47) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL2327566 0.68 MIF (0.47) ALDH1A1MAPTRAB9AESR1ESR2
SCHEMBL7224651 0.68 ESR1 (0.51) ALDH1A1MAPTESR1ESR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3059231-B1 CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION ARTAX BIOPHARMA INC (US) 2021-02-17 EP disclosed
EP-3059232-B1 CHROMENE DERIVATIVES SUBSTITUTED BY ALKOXIDE AS INHIBITORS OF THE TCR-NCK INTERACTION ARTAX BIOPHARMA INC (US) 2019-01-09 EP disclosed